Women’s Health is a High-Growth Opportunity

Investor Presentation + Research-based Entrepreneur Panel Discussion

Join leading investors and innovators as we explore why women’s health is fast becoming one of the most compelling and undercapitalised frontiers in healthcare.

Despite making up over half the population, women’s health remains significantly underfunded — and that’s exactly where the opportunity lies.

📊 The numbers speak for themselves:
• $14 billion ROI: Doubling investment in research for just a few female-prevalent conditions (like coronary artery disease and Alzheimer’s) could deliver outsized economic and social returns.
• $30 billion by 2030: The women’s health market is growing rapidly and showing no signs of slowing.
• Only 5% of health conditions are exclusive to women — meaning 95% remain an untapped space for innovation that better serves women’s needs.

This event will unpack how smart capital is leaning in — and how we can collectively accelerate innovation, equity, and impact in this high-growth sector.

Hear Maria Lund from IP Group speak about the main reasons why investors are now very interested in this underfunded sector, and thoughts from our panelists Elaine Stead (Main Sequence Ventures), Aleta Knowles (Uniseed) and two research-based entrepreneurs Tara Croft (Baymatob) and Catherine Slogrove (Amelia Bio).

Don’t miss this opportunity to be part of a bold conversation on the future of healthcare — and the women driving it.